Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Cg-Bio Genomics Inc. has 1 pending office action currently active. This action is assigned to a distinct examiner, who is identified as MUKHOPADHYAY, BHASKAR. This examiner is responsible for 1 busiest examiner pending action, which accounts for the entirety of the company's current pending workload. The concentration of the portfolio under a single individual suggests that the prosecution strategy is highly dependent on the specific requirements and examination style of this individual.
The data shows 0 distinct art units associated with these filings at this time. With only a single distinct examiner involved, the prosecution strategy is highly centralized and lacks the diversification seen in larger portfolios. The focus for this portfolio remains on the single pending action and the specific requirements of the assigned examiner. Practitioners should monitor this case closely as it represents the current extent of the company's active patent office interactions.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MUKHOPADHYAY, BHASKAR | 1 | 28.2% | +37.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18900307 | HEALTHFUL SUPPLEMENT FOOD | MUKHOPADHYAY, BHASKAR | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18900307 | HEALTHFUL SUPPLEMENT FOOD | MUKHOPADHYAY, BHASKAR | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18900307 | HEALTHFUL SUPPLEMENT FOOD | MUKHOPADHYAY, BHASKAR | — | §102 | Non-Final OA | — | Pending | Sep 27, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial